IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease

This publication has 24 references indexed in Scilit:

• Expression of the β-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue
  Journal of Neuroimmunology, 2000
• Expression of the interferon‐γ‐inducible chemokines IP‐10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions
  Neuropathology and Applied Neurobiology, 2000
• CCR5⁺and CXCR3⁺T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions
  Proceedings of the National Academy of Sciences, 1999
• Expression of monocyte chemoattractant protein-1 and other β-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions
  Journal of Neuroimmunology, 1998
• Chemokines in the Cerebrospinal Fluid of Patients with Meningitis
  Clinical Immunology and Immunopathology, 1996
• Qualitative assessment of intrathecal IgG synthesis by isoelectric focusing and immunodetection: Interlaboratory reproducibility and interobserver agreement
  Scandinavian Journal of Clinical and Laboratory Investigation, 1996
• Human Mig chemokine: biochemical and functional characterization.
  The Journal of Experimental Medicine, 1995
• Major differences in the dynamics of primary and secondary progressive multiple sclerosis
  Annals of Neurology, 1991
• New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
  Annals of Neurology, 1983
• Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values
  Scandinavian Journal of Clinical and Laboratory Investigation, 1977